Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates

被引:9
|
作者
Schouten, MA
HoogkampKorstanje, JAA
机构
[1] Department of Medical Microbiology, University Hospital St Radboud, 6500 HB Nijmegen
关键词
D O I
10.1093/jac/40.2.213
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in-vitro activity of quinupristin-dalfopristin was compared with those of vancomycin, teicoplanin, erythromycin, clarithromycin, rifampicin, imipenem, meropenem, ciprofloxacin and sparfloxacin against 414 bloodstream isolates of Gram-positive cocci. Quinupristin-dalfopristin inhibited strains of Streptococcus pyogenes and Streptococcus agalactiae at 0.12 mg/L, methicillin- and/or erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis at 0.5 mg/L, Staphylococcus haemolyticus, Enterococcus faecium, Streptococcus pneumoniae, Streptococcus mitis, Streptococcus bovis, Streptococcus sanguis and Streptococcus anginosus at 1 mg/L and Enterococcus faecalis at 8 mg/L.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 50 条
  • [1] Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center
    Smith, PF
    Booker, BM
    Ogundele, AB
    Kelchin, P
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) : 255 - 259
  • [2] Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan
    Luh, KT
    Hsueh, PR
    Teng, LJ
    Pan, HJ
    Chen, YC
    Lu, JJ
    Wu, JJ
    Ho, SW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3374 - 3380
  • [3] Quinupristin-dalfopristin: A new antibiotic for severe gram-positive infections
    Manzella, JP
    AMERICAN FAMILY PHYSICIAN, 2001, 64 (11) : 1863 - 1866
  • [4] In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates
    Goldstein, EJC
    Citron, DM
    Merriam, CV
    Warren, YA
    Tyrrell, KL
    Fernandez, HT
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 337 - 341
  • [5] In vitro activity of quinupristin/dalfopristin against clinical isolates of common Gram-positive bacteria in Taiwan
    Chang, SC
    Fang, CT
    Hsueh, PR
    Luh, KT
    Hsieh, WC
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (04) : 299 - 303
  • [6] In vitro activity of quinupristin/dalfopristin, RP59500, against gram-positive clinical isolates
    Qadri, SMH
    Ueno, Y
    AbuMostafa, FM
    Halim, M
    CHEMOTHERAPY, 1997, 43 (02) : 94 - 99
  • [7] In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci
    Tünger, A
    Aydemir, S
    Uluer, S
    Cilli, F
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2004, 120 (06) : 546 - 552
  • [8] Quinupristin-dalfopristin resistance in gram-positive bacteria: Mechanism of resistance and epidemiology
    Hershberger, E
    Donabedian, S
    Konstantinou, K
    Zervos, MJ
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (01) : 92 - 98
  • [9] Susceptibility to quinupristin-dalfopristin and linezolid in 839 clinical isolates of gram-positive cocci from Norway
    Simonsen, GS
    Bergh, K
    Bevanger, L
    Digranes, A
    Gaustad, P
    Melby, KK
    Hoiby, EA
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (04) : 254 - 258
  • [10] Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin
    von Eiff, C
    Reinert, RR
    Kresken, M
    Brauers, J
    Hafner, D
    Peters, G
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (08) : 2819 - 2823